FDA under pressure to clamp down on clinical trial fraud
The US Food and Drug Administration (FDA) has outlined a series of imminent changes to the way it evaluates clinical trials in an attempt to clamp down on fraud.
Archives for July 24, 2006
New specialty chemicals company is born
A new specialty chemicals company, Vertellus Specialties, has been created in the US to make high-growth and high-value pharmaceuticals.
Pharmaceutical industry flushed with IT services
The pharmaceutical and life sciences industries are flushed with quality IT services, with eight companies that have a specialist life science/pharmaceutical focus being featured in the top 20 of the first-ever listing of the world's top outsourcing...
New white paper assists labs to maintain standards
A new white paper has been made available to laboratories worldwide, which aims to minimise the risk of infection through focused biosafety reviews and further reinforce the required level of infection control.
Concept aids drug researchers in screening compounds
A new concept to develop a more accurate method for rapidly screening chemical compounds has been unveiled, which the researchers say will significantly aid in identifying leads for drug development and discovery.
Kamada holds transferrin supply monopoly
Israeli biopharma firm Kamada will manufacture transferrin for an undisclosed European pharma firm embarking on the first ever clinical trials of a drug that includes the substance.
Japanese firm to make modified Tamiflu dry syrup
Chugai Pharmaceutical has decided to manufacture a modified version of Roche's Tamiflu (oseltamivir) in a dry syrup formulation which can be stored at room temperature after the bottle is opened, allowing for more storage capacity as fears of a...